Stock Fundamentals

Company Information

Company Name
Foghorn Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US3441741077
CIK: 0001822462
CUSIP: 344174107
Currency: USD
Full Time Employees: 106
Phone: 617 586 3100
Fiscal Year End: December
IPO Date: Oct 23, 2020
Description:

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing therapies for mutant; non-small cell lung; endometrial, cervical, ovarian, and bladder cancer; and diffuse large B-cell lymphoma, as well as various acute myeloid leukemia and myelodysplastic syndrome. The company has collaboration agreement with Eli Lilly and Company for developing FHD-909, a selective ATPase inhibitor of BRM. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Address:

99 Coolidge Avenue, Watertown, MA, United States, 02472

Directors & Officers

Name Title Year Born
Mr. Adrian H. B. Gottschalk President, CEO & Director 1976
Dr. Steven F. Bellon Ph.D. Chief Scientific Officer 1965
Dr. Alfonso Quintas Cardama M.D. Chief Medical Officer 1971
Dr. Gerald R. Crabtree M.d. Founder & Member of Scientific Advisory Board NA
Mr. Ryan D. Maynard Chief Financial Officer 1969
Ms. Karin Hellsvik Chief of Staff to the CEO, VP, Head of Corporate Affairs, Investor Relations & Operations NA
Mr. Michael J. LaCascia J.D. Chief Legal Officer 1965
Mr. Saurabh Sewak Ph.D. Vice President of Corporate Development NA
Mr. Carlos Costa Chief People Officer 1973
Dr. Anna Rivkin Ph.D. Chief Business Officer 1975

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 23, 2024 Carlos Costa N/A Sale 857.00 $10.17 $8.72K
Sep 20, 2024 Carlos Costa N/A Sale 35.76K $10.04 $358.99K
Aug 16, 2023 Samuel Agresta N/A Sale 311.30K $8.25 $2.57M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Flagship Ventures Management, Inc. 12.67M Mar 31, 2026 21.59% $5.22 0.00%
FMR Inc 6.05M Mar 31, 2026 10.30% $0.00 12.05%
Bvf Inc 5.84M Mar 31, 2026 9.95% $0.89 10.18%
Deerfield Management Co 4.39M Mar 31, 2026 7.48% $0.25 20.42%
BlackRock Inc 2.36M Mar 31, 2026 4.03% $0.00 0.64%
Vanguard Group Inc 1.93M Dec 31, 2025 3.29% $0.00 1.55%
Euclidean Capital LLC 1.57M Mar 31, 2026 2.68% $1.92 0.00%
Geode Capital Management, LLC 848.17K Mar 31, 2026 1.44% $0.00 6.68%
Siren, L.L.C. 720.72K Mar 31, 2026 1.23% $0.10 0.00%
State Street Corp 679.79K Mar 31, 2026 1.16% $0.00 9.88%
Ameriprise Financial Inc 448.98K Mar 31, 2026 0.76% $0.00 -26.12%
Renaissance Technologies Corp 406.43K Mar 31, 2026 0.69% $0.00 36.51%
Candriam Luxembourg S.C.A. 313.77K Mar 31, 2026 0.53% $0.01 0.00%
Jacobs Levy Equity Management, Inc. 303.76K Mar 31, 2026 0.52% $0.01 12.84%
Birchview Capital, LP 281.73K Mar 31, 2026 0.48% $0.77 0.00%
Northern Trust Corp 275.88K Mar 31, 2026 0.47% $0.00 5.12%
Citadel Advisors Llc 200.01K Mar 31, 2026 0.34% $0.00 9.73%
Woodline Partners LP 180.33K Mar 31, 2026 0.31% $0.00 737.86%
The Goldman Sachs Group Inc 136.11K Mar 31, 2026 0.23% $0.00 14.66%
Sio Capital Management, LLC 122.89K Mar 31, 2026 0.21% $0.08 0.00%

Shares Statistics

Shares Outstanding: 58.71M
Shares Float: 27.41M
% Insiders: 1,794.10%
% Institutions: 7,656.70%
Short % Float: 4.19%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Growth Compy Commingled Pl S 2.72M 4.63% ▲ 0.12% Mar 31, 2026
2 Fidelity Growth Company Fund 1.84M 3.13% ▲ 0.00% Mar 31, 2026
3 Vanguard Total Stock Mkt Idx Inv 1.03M 1.75% ▲ 0.00% Apr 30, 2026
4 iShares Russell 2000 ETF 759.21K 1.29% ▲ 0.85% Apr 30, 2026
5 Fidelity Select Biotechnology 654.28K 1.11% ▲ 0.00% Mar 31, 2026
6 Fidelity Growth Company K6 504.26K 0.86% ▼ 0.65% Mar 31, 2026
7 Vanguard Institutional Extnd Mkt Idx Tr 429.78K 0.73% ▲ 0.00% Apr 30, 2026
8 Fidelity Small Cap Index 327.57K 0.56% ▼ 0.40% Feb 28, 2026
9 Fidelity Series Growth Company 327.31K 0.56% ▲ 0.00% Mar 31, 2026
10 iShares Biotechnology ETF 219.94K 0.37% ▲ 0.64% Apr 30, 2026

Valuation Metrics

Enterprise Value: $91.75M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $213.13M
EBITDA: $-78.02M
Book Value: $-1.30
Earnings/Share: $-1.17
Profit Margin: -266.88%
Operating Margin: -660.33%
ROA (TTM): -21.00%
ROE (TTM): -470.38%
Revenue (TTM): $28.22M
Revenue/Share (TTM): $0.44
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -45.10%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 2.73x -0.01x 1.55x N/A -0.01x
2024-12-31 3.73x -0.20x 1.16x N/A -0.09x
2023-12-31 4.11x -0.11x 1.27x N/A -0.08x
2022-12-31 6.37x 53.30x 1.00x -10.13x -0.05x
2021-12-31 9.44x 0.07x 0.81x -52.85x -0.07x
2020-12-31 10.12x 0.16x 0.43x -70.00x -0.35x
2019-12-31 1.33x -0.19x 4.94x -94.60x -0.34x
2018-12-31 11.68x -0.18x 1.91x -70.21x -0.27x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about FHTX.US!